Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAPATINIB vs LAROTRECTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LAPATINIB vs LAROTRECTINIB: Safety Overview

Metric LAPATINIB LAROTRECTINIB
Total FAERS Reports 1,983 798
Deaths Reported 267 149
Death Rate 13.5% 18.7%
Hospitalizations 498 151
Average Patient Age 54.1 yrs 48.9 yrs
% Female Patients 96.6% 51.5%
FDA Approval Date N/A Nov 26, 2018
Manufacturer N/A Bayer HealthCare Pharmaceuticals Inc.
Route N/A ORAL
Marketing Status N/A Prescription